[Role of splenectomy in the treatment of myelofibrosis].

PubWeight™: 0.77‹?›

🔗 View Article (PMID 24137967)

Published in Ter Arkh on January 01, 2013

Authors

A L Melikian, L Iu Kolosova, M A Sokolova, A M Kovrigina, M A Silaev, E A Giliazitdinova, É G Gemdzhian, S R Karagiulian

Articles by these authors

[The incidence of ischemic heart disease and its risk factors in 20- to 54-year-old male workers in physical and intellectual jobs]. Ter Arkh (1992) 1.19

A new simplified method of selective exposure of hepatic pedicles for controlled hepatectomies. HPB Surg (1989) 1.05

[Analysis of the suffix short retroelement copies and the encoded protein domain of Drosophila]. Genetika (2002) 0.94

[Synchronous and metachronous myeloid and lymphoid tumors]. Ter Arkh (2014) 0.82

[The dependence of the clonogenic fibroblast proliferation of human bone marrow on the feeder]. Eksp Onkol (1989) 0.82

[A case of legionellesis pneumonia verified by isolation of Legionella pneumophila serogroup 1 from bronchoalveolar lavage fluid treated with levofloxacine and tigecycline]. Ter Arkh (2011) 0.81

[Analysis of Suffix--short Drosophila retroelement--in the heterochromatin region]. Dokl Akad Nauk (1998) 0.80

[Use of polymerase chain reaction for determining T-cell clonality]. Ter Arkh (2003) 0.80

Studies of P-glycoprotein in chronic myelogenous leukaemia patients: expression, activity and correlations with CD34 antigen. Br J Haematol (1996) 0.79

[A comparison of the forms of chronic lympholeukemia in relation to the mutational status of the genes of the immunoglobulin variable region]. Ter Arkh (2000) 0.78

[Stomach MALT-lymphoma with marked plasmocytic differentiation: a variant of Mott's cell tumor]. Arkh Patol (2004) 0.77

[Determination of T-cell clonicity by a T-cell receptor gamma-chain: final data]. Ter Arkh (2006) 0.77

[Hypercoagulation syndrome in multiple myeloma]. Ter Arkh (2014) 0.75

[Reduced cell sensitivity to glucocorticoid hormones in hypercholesterolemia]. Biokhimiia (1989) 0.75

[Principles of the maximum development of the reserve potentialities of the bone marrow CFUf system following exposure to ionizing radiation]. Radiobiologiia (1989) 0.75

[Differential diagnosis of B-cell lymphoma rich in T cells and peripheral T-cell lymphomas]. Arkh Patol (2000) 0.75

[Evaluation of tumor vascularization and microenvironment in follicular lymphoma]. Ter Arkh (2013) 0.75

[Effect of erythrocytapheresis on the oxygen-transport function of the blood in patients with polycythemia vera]. Gematol Transfuziol (1986) 0.75

[Prediction of interferon therapy efficacy in chronic myeloid leukemia according to data of histomorphological study]. Ter Arkh (2004) 0.75

[The hypotensive effect and tolerance of valsartan (Diovan) in hypertension in a general clinical practice]. Ter Arkh (1999) 0.75

[A modern therapeutic strategy in Ph-positive chronic myeloleukemia]. Ter Arkh (1996) 0.75

[Erythrocytapheresis in the complex treatment of polycythemia vera]. Gematol Transfuziol (1987) 0.75

[Histiocytic sarcoma from phagocyting histiocytes]. Arkh Patol (2004) 0.75

[Malignant mesodermal (Mullerian) mixed tumor of the ovary: histologic, immunohistochemical and cytologic study]. Arkh Patol (1998) 0.75

[A case of cat scratch disease in a patient with diabetes mellitus and chronic renal failure]. Klin Med (Mosk) (2006) 0.75

[Castleman's disease]. Ter Arkh (2005) 0.75

[Mastocytosis. Review of the literature and description of clinical cases]. Ter Arkh (2014) 0.75

[Reaction of the system of bone marrow fibroblast precursor cells to exposure to ionizing radiation]. Patol Fiziol Eksp Ter (1987) 0.75

[The surgical treatment of the late recurrence of the colon cancer]. Khirurgiia (Mosk) (2013) 0.75

[Differential diagnosis of rheumatic diseases and blood cancers involving the nasal cavity and accessory sinuses]. Ter Arkh (2014) 0.75

[Immunohistochemical technique in hemopathology: the ways of improving differential diagnosis and the prospects]. Arkh Patol (2009) 0.75

[Changes in the physicochemical characteristics of low-density lipoproteins following a single fat load]. Fiziol Cheloveka (1992) 0.75

[Nodular lymphocyte-predominant Hodgkin's lymphoma: Principles of diagnosis and treatment]. Ter Arkh (2015) 0.75

[Paraneoplastic lymphadenopathy]. Ter Arkh (2007) 0.75

[Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy]. Ter Arkh (2006) 0.75

[Clinical significance of erythrocyte ferritin in refractory anemia and chronic myeloid leukemia]. Ter Arkh (2002) 0.75

[Effect of erythrocytophoresis on the kinetics of the proliferation of the erythroid cells of bone marrow in patients with polycythemia vera]. Gematol Transfuziol (1984) 0.75

Characteristics of the plasma lipid profile in the male population of Tallinn aged 20-54 years. Cor Vasa (1990) 0.75

[Genetic bases of diversity of the repertoire of immunoglobulins in application to diagnostics of clonality of B-cell lymphoid populations]. Genetika (2011) 0.75

[An analysis of the cell composition of the reserve population in the colony-forming unit system of bone marrow fibroblasts under the action of ionizing radiation]. Patol Fiziol Eksp Ter (1990) 0.75

[Morphoimmunohistological differential diagnosis between Hodgkin's lymphoma with lymphoid prevalence and large B-cell lymphoma]. Arkh Patol (2005) 0.75

[Successful treatment of a patient with two hematologic tumors: double-hit lymphoma and acute myelomonoblastic leukemia]. Ter Arkh (2014) 0.75

[LMP1 gene variants of Epstein-Barr virus in patients with some lymphoproliferative malignancies]. Vopr Virusol (2006) 0.75

[Lymphocytoma of the spleen--a separate nosological form requiring a specific management procedure]. Ter Arkh (1996) 0.75

[A new antiplatelet drug agrilin in treating patients with hyperthrombocytosis]. Ter Arkh (2002) 0.75

[The role of parotid gland biopsy in early detection of lymphoma in primary Sjogren's syndrome]. Ter Arkh (2009) 0.75

[Chalone content of the blood of polycythemia vera patients following bloodletting]. Gematol Transfuziol (1986) 0.75

[Hereditary spherocytic hemolytic anemia in an adult with the formation of ectopic foci of extramedullary hemopoiesis in the chest]. Ter Arkh (2010) 0.75

[MALT gastric lymphoma--principles of morphological diagnosis]. Arkh Patol (2003) 0.75

[Blood lipids as a factor of hereditary susceptibility to ischemic heart disease]. Kardiologiia (1989) 0.75

[Spleen removal in hematological patients with splenomegaly]. Khirurgiia (Mosk) (2012) 0.75

[Patterns in the compensatory reaction of the precursor cell system of the bone marrow fibroblasts to ionizing radiation]. Patol Fiziol Eksp Ter (1991) 0.75

[Successful use of vemurafenib in a patient with resistant hairy cell leukemia]. Ter Arkh (2013) 0.75

[Interferon alfa-2b treatment of adult patients during early chronic phase of Ph1-positive chronic myeloid leukemia (initial report on a cooperative study, protocol CML-MIG-97)]. Ter Arkh (1999) 0.75

[The first experience of external quality control of immunohistochemical studies in the diagnosis of lymphoproliferative diseases]. Arkh Patol (2011) 0.75

[Clinical and morphological aspects of MALT-gastric lymphoma]. Eksp Klin Gastroenterol (2010) 0.75

[First experience with the application of rituximab for the treatment of patients with Sjogren's syndrome and disease]. Vestn Ross Akad Med Nauk (2009) 0.75

[Difficulties in forensic medical evaluation of some forms of craniocerebral injury]. Sud Med Ekspert (2002) 0.75

[Diagnosis of anaplastic large-cell lymphoma]. Arkh Patol (2006) 0.75

[A case of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) in a patient with diffuse large B-cell lymphoma and chronic hepatitis B virus infection]. Ter Arkh (2012) 0.75

[Primary mediastinal (thymic) large B-cell lymphoma: review of the literature and author's own data]. Ter Arkh (2011) 0.75

[IgG4-related disease: patient group characterization and rituximab therapy]. Ter Arkh (2013) 0.75

[Erythron in patients with polycythemia vera during treatment by erythrocytapheresis and bloodletting]. Ter Arkh (1987) 0.75

[Factors of an unfavorable prognosis in patients with B-cell chronic lymphoid leukemia: a retrospective analysis of 206 cases]. Ter Arkh (2003) 0.75

[Immunological analysis of the content of erythrocyte chalone factors in the blood in certain types of pathology]. Gematol Transfuziol (1985) 0.75

[The effect of a diet enriched with omega-3 polyunsaturated fatty acids on thrombocyte functional activity and on the blood lipid-apolipoprotein spectrum in newly occurring stenocardia]. Ter Arkh (1990) 0.75

[Non-Hodgkin's lymphoma of the stomach. A case report]. Eksp Klin Gastroenterol (2010) 0.75

[Nine-year experience in the treatment of patients with diffuse large B-cell lymphosarcoma]. Ter Arkh (2011) 0.75

[Cytomorphological diagnosis of granulosa cell tumor of the ovary]. Klin Lab Diagn (1998) 0.75

Characteristics of the blood serum lipoprotein pattern in female Tallinn residents aged 35-54 years. Cor Vasa (1991) 0.75

[Morphoimmunohistochemical differential diagnosis of B-cell lymphomas]. Arkh Patol (2006) 0.75

[Tumor development from follicular dendritic cells in a hyaline-vascular variant of Castleman's disease]. Ter Arkh (2009) 0.75

[Interrelation between the genetic markers of blood and lipids in a population]. Kardiologiia (1987) 0.75

[Transthoracic splenectomy in a patient with severe thrombocytopenia and pancreatic tail pseudocyst]. Khirurgiia (Mosk) (2012) 0.75

[Bone marrow alterations in sarcoidosis]. Arkh Patol (2004) 0.75

[A benign form of chronic lympholeukemia]. Ter Arkh (1997) 0.75

[B-cell lymphoma, unclassifiable, intermediate between diffuse large B-cell lymphoma and Burkitt's lymphoma]. Ter Arkh (2015) 0.75

[Feasibilities of cytological diagnosis in the static telepathology mode]. Klin Lab Diagn (1999) 0.75

[Lymphoproliferative diseases of the orbit and appendages of the eye]. Arkh Patol (2001) 0.75

[The clinical significance of the expression of the multiple-drug resistance protein P-glycoprotein in chronic myeloleukemia]. Ter Arkh (1995) 0.75

[Chronic lymphocytic leukemia accompanied by renal failure]. Ter Arkh (2014) 0.75

[The estimation of thrombocytopoiesis using automated blood analyzers]. Klin Lab Diagn (2001) 0.75

[Experience with high-dose chemotherapy in patients with testicular diffuse large B-cell lymphoma]. Ter Arkh (2014) 0.75

[MALT-lymphomas in Sjogren's disease]. Ter Arkh (2006) 0.75

[The effect of the 5'-leader of potato X-virus on expression of the gene for the potato Y virus membrane protein in transgenic Solanum tuberosum]. Mol Biol (Mosk) (1995) 0.75

[Hemodynamic indices in patients with polycythemia vera during treatment by erythrocyte pheresis]. Gematol Transfuziol (1986) 0.75

[Characteristics of the blood lipoprotein spectrum in truck drivers from the rural Northern Caucasus areas]. Gig Tr Prof Zabol (1991) 0.75

[Successful therapy for enteropathy-associated peripheral T-cell lymphoma using high-dose polychemotherapy and autologous hematopoietic stem cell transplantation]. Ter Arkh (2013) 0.75

[LMP1 gene polymorphism in patients with Epstein-Barr virus-negative gastric carcinomas in Russia]. Vopr Virusol (2011) 0.75

[The value of monitoring of qualitative content of onco-antigens in serum in diagnostics of malignant tumors]. Klin Lab Diagn (2012) 0.75

[Bartonella infection in hematological practice]. Ter Arkh (2007) 0.75

[Changes in high density lipoprotein subfractions during interaction with fibroblasts and hepatoma G-2 in various dyslipidemias]. Vopr Med Khim (1991) 0.75

[Investigation of β-endorphin concentrations in patients with hemophilia]. Ter Arkh (2013) 0.75

[Acute abdominal syndrome in blood system diseases]. Ter Arkh (2010) 0.75

[The role of morphological characteristics of lymph nodes in differential diagnosis of reactive lymphadenopathies]. Ter Arkh (2005) 0.75

[Characteristics of the lipid spectrum in miners]. Kardiologiia (1991) 0.75